41
Views
2
CrossRef citations to date
0
Altmetric
Reviews

The future of predictive biosimulation in drug discovery

&
Pages 515-523 | Published online: 14 May 2007

Bibliography

  • DIMASI J, HANSEN R, GRABOWSKI H: The price of innovation: new estimates of drug development costs. J. Health Econ. (2003) 22:151-185.
  • KIGHTLEY DA, CHANDRA N, ELLISTON K: Inferring gene regulatory networks from raw data: a molecular epistemics approach. Pacific Symposium on Biocomputing (2004) 9:498-509.
  • KING RD, WHELAN KE, JONES FM et al.: Functional genomic hypothesis generation and experimentation by a robot scientist. Nature (2004) 427:247-252.
  • CHAKRABORTY AK, DUSTIN ML, SHAW AS: In silico models for cellular and molecular immunology: successes, promises and challenges. Nat. Immunol. (2003) 4:933-936.
  • FRIEDRICH CM, PATERSON TS: In silico predictions of target clinical efficacy. Drug Discov. Today (2004) 3:216-222.
  • HO RL: Biosystems modelling for in silico target validation: challenges to implementation. Emerg. Ther. Targets (2000) 4:699-714.
  • NOBLE D, LEVIN J, SCOTT W: Biological simulations in drug discovery. Drug Discov. Today (1999) 4:10-16.
  • NOBLE D: Modeling the heart – from genes to cells to the whole organ. Science (2002) 295:1678-1682.
  • HALL K, BAILLIE R, MICHELSON S: Biosimulation: dynamic modeling of biological systems. Ann. Rep. Med. Chem. (2002) 37:279-288.
  • MUSANTE CJ, LEWIS AK, HALL K: Small- and large-scale biosimulation applied to drug discovery and development. Drug Discov. Today (2002) 7(20) (Suppl.): S192-S196.
  • SOMOGYI R, GRELLER LD: The dynamics of molecular networks: applications to therapeutic discovery. Drug Discov. Today (2001) 6:1267-1277.
  • SCHERRER D, FRENCH JM, MICHELSON S: Assessing the impact of biosimulation on target selection and validation. Biosilico (2003) 1:184-188.
  • LEWIS AK, PATERSON T, LEONG C et al.: The roles of cells and mediators in a computer model of chronic asthma. Int. Arch. Allergy Imm. (2001) 124:282-286.
  • ARAKELYAN L, MERBL Y, AGUR Z: Vessel maturation effects on tumor growth: validation of a computer model in implanted human carcinoma spheroids. Eur. J. Cancer (2005) 41:159-167.
  • ARAKELYAN L, VAINSTEIN V, AGUR Z: A computer algorithm describing the process of vessel formation and maturation, and its use for predicting the effects of anti-angiogenic and anti-maturation therapy on vascular tumor growth. Angiogenesis (2002) 5:203-214.
  • HART D, SHOCHAT E, AGUR Z: The growth law of primary breast cancer as inferred from mammography screening trials data. Br. J. Cancer (1998) 78(3):382-387.
  • KANSAL A, TRIMMER J: Application of predictive biosimulation within pharmaceutical clinical development: examples of significance for translational medicine and clinical trial design. IEE Proc-Syst. Biol. (2006) 152:214-220.
  • MICHELSON S, SEHGAL A, FRIEDRICH CM: In silico prediction of clinical efficacy. Curr. Opin. Biotech. (2006) 17:1-5.
  • MICHELSON S: The impact of systems biology and biosimulation on drug discovery and development. Mol. Biosyst. (2006) 2:288-291.
  • CHIEN JY, FRIEDRICH S, HEATHMAN MA et al.: Pharmacokinetics/pharmacodynamics and the stages of drug development: role of modeling and simulation. AAPS J. (2005) 7:E544-E559.

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.